# Telemonitoring to Treat Group 2 Pulmonary Hypertension

> **NCT04882774** · PHASE2 · WITHDRAWN · sponsor: **Mardi Gomberg -Maitland MD, MSc**

## Conditions studied

- Pulmonary Hypertension Due to Left Heart Disease

## Interventions

- **DRUG:** Treprostinil Diolamine

## Key facts

- **NCT ID:** NCT04882774
- **Lead sponsor:** Mardi Gomberg -Maitland MD, MSc
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-04
- **Primary completion:** 2025-04
- **Final completion:** 2027-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** never opened to enrollment because it was never funded
- **Last updated:** 2023-06-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04882774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04882774, "Telemonitoring to Treat Group 2 Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04882774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*